Evidence map›Paper›PMID 28270450›Full record

ArticleBlood2017

Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

Wei Shi, Therese Vu, Didier Boucher, Anna Biernacka, Jules Nde, Raj K Pandita, Jasmin Straube, Glen M Boyle, Fares Al-Ejeh, Purba Nag and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 4 countries.

Wei ShiQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Therese VuQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Didier BoucherQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Anna BiernackaLaboratory of Bioinformatics and Systems Biology, Center of New Technologies, University of Warsaw, Warsaw, Poland.
Jules NdeDepartment of Biochemistry & Molecular Biology, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX.
Raj K PanditaDepartment of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX.
Jasmin StraubeQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Glen M BoyleQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Fares Al-EjehQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Purba NagQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.ORCID 0000-0002-6863-5438
Jessie JefferyQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Janelle L HarrisQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Amanda L BainQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Marta GrzelakLaboratory of Bioinformatics and Systems Biology, Center of New Technologies, University of Warsaw, Warsaw, Poland.
Magdalena SkrzypczakLaboratory of Bioinformatics and Systems Biology, Center of New Technologies, University of Warsaw, Warsaw, Poland.
Abhishek MitraDepartment of Biochemistry & Molecular Biology, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX.
Norbert DojerDepartment of Biochemistry & Molecular Biology, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX.
Nicola CrosettoScience for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Nicole CloonanQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Olivier J BecherelSchool of Medicine, University of Queensland, Brisbane, QLD, Australia.
John FinnieSouth Australia Pathology and School of Veterinary Science, University of Adelaide, Adelaide, SA, Australia.
Jeffrey R SkaarDepartment of Pathology, Cancer Institute, New York University School of Medicine, New York, NY.
Carl R WalkleySt. Vincent's Institute of Medical Research and Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, VIC, Australia; and.
Tej K PanditaDepartment of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX.
Maga RowickaDepartment of Biochemistry & Molecular Biology, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX.
Krzysztof GinalskiLaboratory of Bioinformatics and Systems Biology, Center of New Technologies, University of Warsaw, Warsaw, Poland.
Steven W LaneQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.ORCID 0000-0002-8050-6209
Kum Kum KhannaQIMR Berghofer Medical Research Institute, Herston, QLD, Australia.ORCID 0000-0001-8650-5381
QIMR Berghofer Medical Research Institute · AUThe University of Texas Medical Branch at Galveston · USUniversity of Warsaw · PLThe University of Queensland · AUHouston Methodist · USGriffith University · AUNew York University · USScience for Life Laboratory · SESouth Australia Pathology · AUSt Vincent's Hospital Melbourne · AU

Funding

CHROMATIN MODIFYING FACTORS CONTROL RADIATION RESPONSE AND GENOMIC STABILITYR01CA129537 · NCI · WASHINGTON UNIVERSITY · PI PANDITA, TEJ K · 2008 to 2018
$3.3M
Decoding Genome Instability by Combining Accurate Mapping and Predictive ModelingR01GM112131 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ROWICKA, MAGA MALGORZATA · 2014 to 2023
$3.2M
Tumor-cell-specific targets for combined hyperthermia and radiation effectsR01CA154320 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI PANDITA, TEJ K · 2010 to 2014
$1.6M
Role of Heterochromatin protein 1 Beta in Genome Maintenance and OncogenesisR01GM109768 · NIGMS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI PANDITA, TEJ K · 2014 to 2017
$1.2M
NCI NIH HHS R01 CA129537NCI NIH HHS R01 CA154320NIGMS NIH HHS R01 GM109768NIGMS NIH HHS R01 GM112131
6 · The paper itself

Abstract

Hematopoietic stem and progenitor cells (HSPCs) are vulnerable to endogenous damage and defects in DNA repair can limit their function. The 2 single-stranded DNA (ssDNA) binding proteins SSB1 and SSB2 are crucial regulators of the DNA damage response; however, their overlapping roles during normal physiology are incompletely understood. We generated mice in which both

Indexed as

DNA Breaks, Double-StrandedAnimalsCell ProliferationCell SurvivalCpG IslandsGenomic InstabilityHematopoietic Stem CellsMiceMice, KnockoutSuppressor of Cytokine Signaling ProteinsTumor Suppressor Protein p53SSB-1 protein, mouseSSB-4 protein, mouseSuppressor of Cytokine Signaling ProteinsTumor Suppressor Protein p53

Identifiers

PMID28270450
PMCPMC5418634
OpenAlexW2592973683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.